Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626002 · ClinicalTrials.gov registry record · Phase 3
Open Label Continuation Study in Moderate to Severe Psoriasis
A Phase 3 study, sponsored by AbbVie (prior sponsor, Abbott).
- Completed
- Registry status
- Phase 3
- Development phase
- 2,301
- Enrollment target
NCT00626002: Completed Phase 3 study, sponsored by AbbVie (prior sponsor, Abbott).
NCT00626002 is a Phase 3 study that has completed, run by AbbVie (prior sponsor, Abbott). The registered enrollment target is 2,301 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (198% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00626002, a Phase 3 study, has completed, sponsored by AbbVie (prior sponsor, Abbott).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,301 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate long term safety, efficacy and tolerability of ABT-874 in adults with moderate to severe psoriasis.
Interventions
- DRUG ABT-874
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,301 participants |
| Start Date | 2008-02 |
| Est. Completion | 2011-10 |
| Phase | Phase 3 |
What the finished NCT00626002 record still lists
NCT00626002 is an interventional study that assigns participants to a tested intervention. Its 2,301 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (198% higher).
The record links to 0 conditions, and to 1 intervention - of which ABT-874 is the first listed.
NCT00626002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00626002 about?
NCT00626002 is a clinical study titled "Open Label Continuation Study in Moderate to Severe Psoriasis". The purpose of this study is to evaluate long term safety, efficacy and tolerability of ABT-874 in adults with moderate to severe psoriasis.
What is the current status of trial NCT00626002?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,301 participants. The study started on 2008-02. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00626002?
The interventions under investigation include: ABT-874 (DRUG).
Who is sponsoring clinical trial NCT00626002?
This trial is sponsored by AbbVie (prior sponsor, Abbott), which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00626002's enrollment target sits among peer trials
2,301 94th of 2000 higher than 1,907 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- NCT05237258 · 2,300 participants · NA
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
- NCT05732623 · 2,300 participants
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- NCT05759988 · 2,300 participants · NA
Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia